Molecular Screening for Cancer Treatment Optimization (MOSCATO 02)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Gustave Roussy, Cancer Campus, Grand Paris
Sponsor:
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier:
NCT01566019
First received: March 27, 2012
Last updated: July 11, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: October 2019 (Final data collection date for primary outcome measure)